[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Rutgers University withdraws invite to a graduation speaker over his criticism of Israel

Rutgers University has canceled a planned graduation speech by business leader Rami Elghandour after students raised concerns about his criticism of Israel on social media

ACLX : 115.07 (+0.03%)
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Arcellx, Inc. (Nasdaq: ACLX). Under the terms of the transaction,...

ACLX : 115.07 (+0.03%)
GILD : 134.36 (+2.96%)
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ACLX : 115.07 (+0.03%)
MASI : 178.81 (+0.10%)
FONR : 18.90 (-0.24%)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR

NEW YORK , March 18, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...

ACLX : 115.07 (+0.03%)
TALK : 5.20 (+0.19%)
FONR : 18.90 (-0.24%)
UNF : 265.47 (+0.26%)
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ACLX : 115.07 (+0.03%)
GLDD : 17.00 (+0.18%)
MASI : 178.81 (+0.10%)
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Arcellx , Inc....

ACLX : 115.07 (+0.03%)
GILD : 134.36 (+2.96%)
Are ACLX, DBRG, AVO, CVGW Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ACLX : 115.07 (+0.03%)
AVO : 11.92 (-0.17%)
CVGW : 26.45 (-0.04%)
DBRG : 15.71 (+0.06%)
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--ACLX, VRE, EHAB, and CECO

NEW YORK , March 4, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

ACLX : 115.07 (+0.03%)
EHAB : 13.80 (+0.07%)
VRE : 19.00 (+0.05%)
CECE : 11.65 (+2.19%)
Are ACLX, VRE, LSF Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ACLX : 115.07 (+0.03%)
VRE : 19.00 (+0.05%)
LSF : 3.57 (+7.85%)
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?

As Gilead Sciences has outperformed its sector peers recently, analysts remain highly optimistic about the stock’s prospects.

ACLX : 115.07 (+0.03%)
XLV : 149.89 (+1.17%)
MRK : 122.41 (+5.64%)
GILD : 134.36 (+2.96%)

Barchart Exclusives

Investors Pile Into Tesla Call Options in Huge, Unusual Volume - a Bullish Signal?
Investors have piled Tesla call options expiring shortly at an at-the-money strike price. A Barchart report shows that volume for this contract is over 223 times normal. Some investors see TSLA stock as undervalued. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.